vulvar cancer, cervical cancer,endometrial cancer
Conditions
Interventions
Gold Standard:Postoperative pathology (including immunohistochemistry)
Index test:tissue 
dielectric 
properties,sentinel 
lymph 
mapping,sentinel 
biopsy
Sponsors
The First Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) female, aged 18 to 65 years old; (2) vulvar cancer (stage I ~ II), cervical cancer (stage IA2 ~ IB1) and endometrial cancer (stage I) diagnosed by imaging, tissue and / or cytology examinations; (3) there was no history of other tumors (except for squamous cell carcinoma treated by surgery); (4) without surgical contraindication; (5) no history of allergies or adverse reactions to methylene blue; (6) Willing to obey this research project prohibitions and restrictions; (7) the subjects had signed informed consent, indicating that they understood the purpose of the study, the steps and contents of the study, and volunteered to participate in the study.
Exclusion criteria
Exclusion criteria: Subjects in any of the following circumstances could not participate in the study: (1) suffering from mental illness or other conditions, such as uncontrollable heart disease or lung disease, diabetes, etc., can not meet the requirements of research and treatment and monitoring; (2) poor compliance; (3) pregnant and lactating women; (4) any history of allergies or adverse reactions to methylene blue; (5) the ones were enrolled in other clinical trials; (6) the researchers believe that other causes are not appropriate for clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the dielectric properties of lymph node;metastatic status of lymph node;metastatic status of lymph node; | — |
Countries
China
Contacts
Public ContactWamg Wei
The First Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed